Reduction of nanoparticle avidity enhances the selectivity of vascular targeting and PET detection of pulmonary inflammation
about
Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigmRedox regulation of endothelial cell fateIcam-1 targeted nanogels loaded with dexamethasone alleviate pulmonary inflammationComputational Modeling of Tumor Response to Drug Release from Vasculature-Bound NanoparticlesBiophysically inspired model for functionalized nanocarrier adhesion to cell surface: roles of protein expression and mechanical factorsPlatelet-like nanoparticles: mimicking shape, flexibility, and surface biology of platelets to target vascular injuries.Nanotechnology for cancer treatment.Evolution of Multivalent Nanoparticle Adhesion via Specific Molecular Interactions.Collaborative Enhancement of Endothelial Targeting of Nanocarriers by Modulating Platelet-Endothelial Cell Adhesion Molecule-1/CD31 Epitope Engagement.Vascular Accessibility of Endothelial Targeted Ferritin Nanoparticles.Biodistribution and fate of core-labeled 125I polymeric nanocarriers prepared by Flash NanoPrecipitation (FNP).Chitosan-Alginate Microcapsules Provide Gastric Protection and Intestinal Release of ICAM-1-Targeting Nanocarriers, Enabling GI Targeting In Vivo.Nanocarriers for vascular delivery of anti-inflammatory agentsGuiding principles in the design of ligand-targeted nanomedicines.Synthetic multivalency for biological applications.Targeted endothelial nanomedicine for common acute pathological conditions.Targeting specific cells in the brain with nanomedicines for CNS therapiesToward redesigning the PEG surface of nanocarriers for tumor targeting: impact of inner functionalities on size, charge, multivalent binding, and biodistribution.Optimization of Tet1 ligand density in HPMA-co-oligolysine copolymers for targeted neuronal gene delivery.Nanocarrier Hydrodynamics and Binding in Targeted Drug Delivery: Challenges in Numerical Modeling and Experimental Validation.Molecular engineering of antibodies for site-specific covalent conjugation using CRISPR/Cas9.Transporter-Guided Delivery of Nanoparticles to Improve Drug Permeation across Cellular Barriers and Drug Exposure to Selective Cell Types.Effect of wall-mediated hydrodynamic fluctuations on the kinetics of a Brownian nanoparticle.Multifunctional gold nanocomposites designed for targeted CT/MR/optical trimodal imaging of human non-small cell lung cancer cells.
P2860
Q27026630-644114D1-8F69-4B96-A584-B6AFEC9D9BBFQ28392484-312BDCA0-6556-43F2-83D6-0B094263B7DAQ28540684-87891A09-B72E-4298-A0DF-AD8FA7EFD2ABQ28551529-C073EA5D-E74F-4BCB-A3EC-A0FC48EAFFBAQ28596891-FEB030D4-CC9C-46DA-B110-56D79DDAEC54Q34579964-8B863E6B-0C58-4A58-A8E9-328260F639ADQ35737878-46EE5C13-1315-48B2-91F7-ADF247F49898Q36178351-A7D25F83-C296-4241-A0CA-6B478C89C9F1Q36601477-835FC75E-9F64-40D2-9B11-72811D38A49AQ36693096-1A66313B-6C2E-488A-963D-FB7618AF53DAQ36783691-28A898D2-60C4-452A-BCD0-DA143FBFA102Q37051502-7A77D757-D890-424B-9F67-2FFA87F4D0CDQ38176037-3E3CDB43-C713-4026-A60F-154048A7CA4CQ38189490-6F9C7A35-A65E-45B5-B778-F8E9D32EDDE1Q38598783-203247AF-EEB9-4EB2-9CC6-EC9943483E6FQ38598987-A6F2837C-5CF9-48E6-B48E-9FE568AC242FQ38674279-A86F10B9-0C3F-4C33-88FB-23FE15A7D983Q41950691-1D6759D6-B8A8-4B90-A66D-89A11E249243Q42176649-F99BAB39-2974-4D35-B246-A0C25309D723Q43096315-624378D1-96D3-42C9-B377-4A7F0D2C5338Q48147422-8A4975C3-5F06-4097-9C19-37CF4E2867EEQ49472868-81E6045C-0760-4425-82A8-9E358429C814Q51030350-B1E4EBB7-BC28-404E-A5C2-077FE222F858Q51266036-0B24074D-D2F4-4715-99EF-8E1809113418
P2860
Reduction of nanoparticle avidity enhances the selectivity of vascular targeting and PET detection of pulmonary inflammation
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Reduction of nanoparticle avid ...... tion of pulmonary inflammation
@ast
Reduction of nanoparticle avid ...... tion of pulmonary inflammation
@en
type
label
Reduction of nanoparticle avid ...... tion of pulmonary inflammation
@ast
Reduction of nanoparticle avid ...... tion of pulmonary inflammation
@en
prefLabel
Reduction of nanoparticle avid ...... tion of pulmonary inflammation
@ast
Reduction of nanoparticle avid ...... tion of pulmonary inflammation
@en
P2093
P2860
P356
P1433
P1476
Reduction of nanoparticle avid ...... tion of pulmonary inflammation
@en
P2093
Blaine J Zern
Eric R Blankemeyer
Ravi Radhakrishnan
Vladimir Muzykantov
P2860
P304
P356
10.1021/NN305773F
P407
P577
2013-02-08T00:00:00Z